Related Experiment Video
Updated: Jun 26, 2026

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Interhemispheric distribution of Alzheimer disease and vascular pathology in brain aging
Background And Purpose:
Most of the neuropathological studies in brain aging were based on the assumption of a symmetrical right-left hemisphere distribution of both Alzheimer disease and vascular pathology. To explore the impact of asymmetrical lesion formation on cognition, we performed a clinicopathological analysis of 153 cases with mixed pathology except macroinfarcts.
Methods:
Cognitive status was assessed prospectively using the Clinical Dementia Rating scale; neuropathological evaluation included assessment of Braak neurofibrillary tangle and Ass deposition staging, microvascular pathology, and lacunes. The right-left hemisphere differences in neuropathological scores were evaluated using the Wilcoxon signed rank test. The relationship between the interhemispheric distribution of lesions and Clinical Dementia Rating scores was assessed using ordered logistic regression.
Results:
Unlike Braak neurofibrillary tangle and Ass deposition staging, vascular scores were significantly higher in the left hemisphere for all Clinical Dementia Rating scores. A negative relationship was found between Braak neurofibrillary tangle, but not Ass staging, and vascular scores in cases with moderate to severe dementia. In both hemispheres, Braak neurofibrillary tangle staging was the main determinant of cognitive decline followed by vascular scores and Ass deposition staging. The concomitant predominance of Alzheimer disease and vascular pathology in the right hemisphere was associated with significantly higher Clinical Dementia Rating scores.
Conclusions:
Our data show that the cognitive impact of Alzheimer disease and vascular lesions in mixed cases may be assessed unilaterally without major information loss. However, interhemispheric differences and, in particular, increased vascular and Alzheimer disease burden in the right hemisphere may increase the risk for dementia in this group.
Insights
Brain aging studies often assume symmetrical pathology. This study found that asymmetrical Alzheimer disease and vascular pathology, particularly in the right hemisphere, significantly impacts cognitive decline and dementia risk.
Area of Science:
- Neuropathology
- Neuroscience
- Cognitive Aging
Background:
- Investigated clinicopathological analysis of 153 mixed pathology cases, excluding macroinfarcts, to understand asymmetrical lesion impact on cognition.
- Assessed cognitive status using Clinical Dementia Rating (CDR) scale and neuropathology including Braak neurofibrillary tangle (NFT) staging, amyloid-beta (Aβ) deposition staging, microvascular pathology, and lacunes.
Discussion:
- Vascular pathology scores were significantly higher in the left hemisphere across all CDR scores, unlike Braak NFT and Aβ staging.
- A negative relationship existed between Braak NFT staging and vascular scores in moderate to severe dementia.
- Braak NFT staging was the primary determinant of cognitive decline, followed by vascular scores and Aβ deposition staging.
Key Insights:
- Cognitive impact of mixed Alzheimer disease and vascular lesions can be assessed unilaterally with minimal information loss.
- Interhemispheric differences, especially right hemisphere predominance of vascular and Alzheimer disease pathology, elevate dementia risk.
Outlook:
- Future research should focus on targeted interventions for asymmetrical neuropathology.
- Understanding hemispheric lateralization of brain pathology is crucial for accurate dementia risk assessment.
Related Concept Videos
Dementia l: Introduction
Alzheimer Disease ll: Pathophysiology
Alzheimer Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia
The progression of dementia is generally gradual.
Hemorrhagic Stroke ll: Pathophysiology

